To examine if HSD3B1 genotypes influence the expression of individual cell surface genes that are currently drug targets or ones that are associated with immunity, we also performed the focused analysis of a collection of tumor-associated cell surface and immune markers [10] across both BC and EC subtypes and menopausal status (Figure 5B and Supplementary Table S7). This evidence concerns the gene HSD3B1 and neoplasm.